Skip to main content

Summit Global Investments

Position in GILD — Gilead Sciences, Inc.

CIK 1697953 BOUNTIFUL, UT

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,479,694
-$199,853 QoQ
Shares Held
11,712
-2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#932
of 2,266 holders
Holding Since
Jun 2020
17 quarters on record

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. GILD ranks #5 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
11,712 $1,479,694

All Filings in GILD

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,479,694 11,712
2026-03-31 $1,679,547 12,051
2025-12-31 $3,787,879 30,861
2025-09-30 $5,031,519 45,329
2025-06-30 $5,022,743 45,303
2025-03-31 $3,929,593 35,070
2024-12-31 $4,718,259 51,080
2024-03-31 $759,602 10,370
2023-12-31 $8,270,310 102,090
2023-09-30 $14,029,367 187,208
2023-06-30 $14,221,033 184,521
2023-03-31 $16,356,042 197,132
2022-12-31 $19,193,913 223,575
2022-09-30 $15,211,705 246,583
2022-06-30 $12,352,295 199,843
2022-03-31 $11,750,114 197,647
2020-06-30 $1,910,420 24,830